Daniel Radcliffe

WILL A NEW ‘SWEENEY TODD’ MAKE ITS INVESTORS A KILLING? (EXCLUSIVE)

August 23, 2022 by Philip Boroff

Hamilton producer Jeffrey Seller is raising as much as $14.5 million to revive Sweeney Todd on Broadway this spring, a test of whether a big-budget Stephen Sondheim revival can succeed in the post-Sondheim era.

Josh Groban (The Great Comet) will play the vengeful barber and Annaleigh Ashford (Sunday in the Park with George) will play the creative pie maker Mrs. Lovett, according to an operating agreement distributed to investors and reviewed by Broadway Journal. The musical, with a book by Hugh Wheeler, will be staged by Hamilton director Thomas Kail with a full orchestra playing the score, a person familiar with the revival said. (Two prior Broadway revivals, while critically acclaimed, were comparatively small-scale productions.)Continue Reading

THE PLAY BOOM & DERREN BROWN’S ‘SECRET’ AMBITION: WEEKLY WRAP

October 12, 2018 by Philip Boroff

Derren Brown‘s challenge: make a vacant Broadway theater appear out of thin air.

In a conversation with Adam Green at the New Yorker Festival on Oct. 7, the British illusionist said he’s “hopefully doing Broadway next spring, fingers crossed.” Greg Day, his United Kingdom-based spokesman, told Broadway Journal that Brown seeks to bring in Secret later this season. Ben Brantley called the show “enthrallingly baffling” when it played off-Broadway at the Atlantic Theater in 2017.

DANIEL RADCLIFFE, CHERRY JONES & BOBBY CANNAVALE STAR IN A BROADWAY MAVERICK’S SWAN SONG

June 6, 2018 by Philip Boroff

EXCLUSIVE: Conventional wisdom dictates that most new plays need an off-Broadway or out-of-town tryout before they’re Broadway-ready.

Norman Twain didn’t do conventional.

The New York movie and theater producer spent years nurturing The Lifespan of a Fact, a comic-drama about the interplay of facts and truth in the magazine world, based on the 2012 book by John D’Agata and Jim Fingal. Twain sought to open it cold on Broadway, in a starry one act, while putting a cleaver to runaway production costs.